These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22994729)
1. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer. He LJ; Cai MY; Xu GL; Li JJ; Weng ZJ; Xu DZ; Luo GY; Zhu SL; Xie D Asian Pac J Cancer Prev; 2012; 13(7):3173-8. PubMed ID: 22994729 [TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression. Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer. Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951 [TBL] [Abstract][Full Text] [Related]
4. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer. Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945 [TBL] [Abstract][Full Text] [Related]
5. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726 [TBL] [Abstract][Full Text] [Related]
6. Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer. Fornaro L; Faviana P; De Gregorio V; Vivaldi C; Paolicchi E; Masi G; Loupakis F; Sensi E; Lupi C; Fontanini G; Wang Y; Danesi R; Falcone A; Crea F BMC Cancer; 2015 Nov; 15():874. PubMed ID: 26553291 [TBL] [Abstract][Full Text] [Related]
7. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma. Chen S; Chen J; Zhan Q; Zhu Y; Chen H; Deng X; Hou Z; Shen B; Chen Y; Peng C Oncotarget; 2014 Nov; 5(21):10421-33. PubMed ID: 25431952 [TBL] [Abstract][Full Text] [Related]
8. The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Bae WK; Yoo KH; Lee JS; Kim Y; Chung IJ; Park MH; Yoon JH; Furth PA; Hennighausen L Mol Carcinog; 2015 Oct; 54(10):1172-80. PubMed ID: 25043748 [TBL] [Abstract][Full Text] [Related]
9. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients. Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178 [TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2). Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793 [TBL] [Abstract][Full Text] [Related]
11. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer. Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer. Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513 [TBL] [Abstract][Full Text] [Related]
13. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus. Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298 [TBL] [Abstract][Full Text] [Related]
14. Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type, is associated with disease progression and prognosis. Liu J; Liang L; Huang S; Nong L; Li D; Zhang B; Li T Hum Pathol; 2019 Jan; 83():166-176. PubMed ID: 30218753 [TBL] [Abstract][Full Text] [Related]
15. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
16. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer. Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241 [TBL] [Abstract][Full Text] [Related]
17. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters. Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400 [TBL] [Abstract][Full Text] [Related]
18. The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma. Gao SB; Xu B; Ding LH; Zheng QL; Zhang L; Zheng QF; Li SH; Feng ZJ; Wei J; Yin ZY; Hua X; Jin GH J Hepatol; 2014 Oct; 61(4):832-9. PubMed ID: 24845612 [TBL] [Abstract][Full Text] [Related]
19. Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis. Guo L; Yang TF; Liang SC; Guo JX; Wang Q Tumour Biol; 2014 Jul; 35(7):6649-56. PubMed ID: 24705718 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas. Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]